OPTIGO BIOTHERAPEUTICS
Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss from chronic ophthalmic diseases, many of which are currently treated by monthly or bimonthly injections of drugs into the eye(s) by a retina specialist. We believe that by reducing the frequency at which each dose of drug is delivered, we will reduce the inconvenience, discomfort, risk and expense of existing treatments. In doing so, we hope to r... educe the number of patients dropping out of their treatment cycles or having to skip doses due to inconvenient timing. Optigo Bio’s therapies for Age-related Macular Degeneration and Diabetic Retinopathy aim to prevent vision loss from these blinding retinal diseases with far fewer injections into the eye.
OPTIGO BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Status:
Active
Total Funding:
0
Similar Organizations
Palmira Biopharma
Biopharmaceutical company
Symphony Allegro
Biopharmaceutical Company
VinaCohn BioPharmaceutical Company Limited
BioPharmaceutical company
Investors List
Red Thread Ventures
Red Thread Ventures investment in Seed Round - Optigo Biotherapeutics
More informations about "Optigo Biotherapeutics"
About Optigo Biotherapeutics
About Optigo Biotherapeutics. Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss …See details»
Optigo Biotherapeutics - Crunchbase Company Profile …
Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss …See details»
Optigo Biotherapeutics - LinkedIn
Optigo Biotherapeutics | 346 followers on LinkedIn. Lifetime Better Vision | Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge …See details»
Optigo Biotherapeutics Inc. · Optigo Biotherapeutics Inc. · Suite …
Optigo Biotherapeutics Inc. (Corporation# 11536451) is a federal corporation entity registered with Corporations Canada. The incorporation date is January 1, 1970. The principal address is …See details»
Optigo Biotherapeutics Company Profile 2024: …
Optigo Biotherapeutics General Information Description. Developer of eye treatment technology designed to cure chronic ophthalmic diseases. The company's platform offers technology for the treatment of Wet Age-Related …See details»
Optigo Biotherapeutics Company Profile | Management and
Optigo Biotherapeutics Profile and History. Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision …See details»
Team | Optigo Biotherapeutics
Optigo Biotherapeutics' management team combines decades of industry-specific experience in Ophthalmology, developing therapies and successfully bringing products to market.See details»
Optigo Biotherapeutics - Funding, Financials, Valuation & Investors
Dec 1, 2020 Organization. Optigo Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding …See details»
Optigo Biotherapeutics: Drug pipelines, Patents, Clinical trials
Nov 22, 2023 Explore Optigo Biotherapeutics with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Optigo Biotherapeutics - Products, Competitors, Financials, …
Optigo Biotherapeutics is a pre-clinical stage biotherapeutics company focused on developing treatments for retinal diseases. Their main offerings include a novel therapeutic designed to be …See details»
Optigo Biotherapeutics - Company Profile - Tracxn
Nov 21, 2024 Optigo Biotherapeutics ranks 227th among 268 active competitors. 92 of its competitors are funded while 80 have exited. Overall, Optigo Biotherapeutics and its …See details»
Science | Optigo Biotherapeutics
Dry Age-Related Macular Degeneration (AMD) accounts for 90% of AMD cases, affecting over 34 million people globally 11.Late stage of this form, Geographic Atrophy (GA), is the leading …See details»
Optigo Biotherapeutics - Overview, News & Competitors - ZoomInfo
Optigo Biotherapeutics. Manufacturing · Canada · <25 Employees. Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge …See details»
Startup Showcase: Optigo Biotherapeutics Revolutionizes Vision …
Jul 20, 2023 Optigo Biotherapeutics, a Vancouver-based biotherapeutics company, is making waves in the field of ophthalmic diseases by developing cutting-edge treatments that address …See details»
C-Suite Quick Takes: Optigo, Revive Biotech, Unity Biotech, and ...
Optigo is developing binders intended to extend the duration of top-performing intravitreal drugs without compromising efficacy. The company has already had promising results in clinical …See details»
Partnerships | Optigo Biotherapeutics
Our platform improves the longevity of injectable ophthalmology products, where proteins or peptides are delivered intravitreally. We look forward to partnering with ophthalmology …See details»
Optigo Biotherapeutics - OIS Podcast Ep #406: Company Quick …
Houman Hemmati, MD, PhD, Co-Founder & Chief Medical Officer of Optigo Biotherapeutics was honoured to be a guest on OIS Podcast Ep #406, interviewed by Carey...See details»
Copy of Science | OptigoBio
With the aim of reducing barriers to Macular Degeneration treatments, Optigo Bio is developing a truly novel therapy. Wet AMD Therapy Optigo Bio is developing a unique biological therapy to …See details»